A Study to Evaluate the Real-world Experience and Satisfaction Associated With Ofatumumab

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The aim of this study is to assess physician and patient satisfaction with ofatumumab using data collected from physicians and their multiple sclerosis (MS) patients in real-world clinical practice across the United Kingdom (UK), France, Germany, Italy, Spain, China, Japan, and Brazil.
Epistemonikos ID: 38ec1b8c2267ebb3ff19eb27537a7c7a5d61be6c
First added on: Apr 02, 2026